- Home
- HI vs CNTA Comparison
HI vs CNTA Comparison
Compare HI & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HI
- CNTA
- Stock Information
- Founded
- HI 2007
- CNTA 2020
- Country
- HI United States
- CNTA United Kingdom
- Employees
- HI N/A
- CNTA N/A
- Industry
- HI Miscellaneous manufacturing industries
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- HI Consumer Discretionary
- CNTA Health Care
- Exchange
- HI Nasdaq
- CNTA Nasdaq
- Market Cap
- HI 2.3B
- CNTA 2.2B
- IPO Year
- HI N/A
- CNTA 2021
- Fundamental
- Price
- HI $30.90
- CNTA $16.63
- Analyst Decision
- HI Buy
- CNTA Strong Buy
- Analyst Count
- HI 2
- CNTA 8
- Target Price
- HI $36.50
- CNTA $23.00
- AVG Volume (30 Days)
- HI 509.7K
- CNTA 964.8K
- Earning Date
- HI 02-05-2025
- CNTA 03-27-2025
- Dividend Yield
- HI 2.89%
- CNTA N/A
- EPS Growth
- HI N/A
- CNTA N/A
- EPS
- HI N/A
- CNTA N/A
- Revenue
- HI $3,116,400,000.00
- CNTA $6,853,000.00
- Revenue This Year
- HI N/A
- CNTA N/A
- Revenue Next Year
- HI $4.10
- CNTA N/A
- P/E Ratio
- HI N/A
- CNTA N/A
- Revenue Growth
- HI 5.87
- CNTA N/A
- 52 Week Low
- HI $25.11
- CNTA $7.75
- 52 Week High
- HI $50.58
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- HI 39.25
- CNTA 48.19
- Support Level
- HI $29.05
- CNTA $15.50
- Resistance Level
- HI $35.48
- CNTA $18.55
- Average True Range (ATR)
- HI 1.38
- CNTA 1.25
- MACD
- HI -0.27
- CNTA -0.12
- Stochastic Oscillator
- HI 28.69
- CNTA 31.57
About HI Hillenbrand Inc
Hillenbrand Inc is a U.S.-based company that operates through three segments. The Advanced Process Solutions segment designs, develops, manufactures, and services engineered industrial equipment. The Molding Technology Solutions segment offers engineered and customized systems in plastic technology and processing. Batesville designs provides, and markets funeral services and solutions.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.